Skip to content
PICO Portalanswers from OpenAlex

EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer

PaperCitations, authors & open-access status

EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer have?

PICO Portalcitation count

EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer has 1 citations in the OpenAlex counts PICO Portal stores.

When was EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer published?

PICO Portalyear

EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer has 2023 year in the PICO Portal index.

What is the open-access status of EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer?

PICO Portaloa status

EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer has bronze oa status in the PICO Portal index.

What is the DOI of EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer?

PICO Portaldoi

The DOI for EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer is on the source record.

What is the OpenAlex record for EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer?

PICO Portalopenalex

The OpenAlex for EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial